FdaApplication
NDA 205382
Identifiers
- fda_app_no: NDA205382
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE |
| application_type | NDA |
| approval_date | 2014-04-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| INCRUSE ELLIPTA | UMECLIDINIUM BROMIDE | EQ 0.0625MG BASE/INH | POWDER;INHALATION |
1 product